Covered recipient · General Payments record
JUDY DIEP
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2023–2024
$1,356.89
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $940.38 | 33 |
| Education | $68.50 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| TG THERAPEUTICS, INC. | $240.35 | 2 |
| Biogen, Inc. | $159.93 | 8 |
| ABBVIE INC. | $148.38 | 10 |
| EMD Serono, Inc. | $124.99 | 1 |
| GENZYME CORPORATION | $121.38 | 1 |
| Celgene Corporation | $30.97 | 2 |
| Teva Pharmaceuticals USA, Inc. | $30.56 | 2 |
| UCB, Inc. | $29.64 | 2 |
| Neurocrine BioSciences, Inc. | $20.50 | 1 |
| ANI Pharmaceuticals, Inc. | $19.50 | 1 |
| SK Life Science, Inc. | $18.73 | 1 |
| Vanda Pharmaceuticals Inc. | $17.59 | 1 |
| Amgen Inc. | $16.57 | 1 |
| Lilly USA, LLC | $15.06 | 1 |
| Philips Electronics North America Corporation | $14.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.84 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103640816 | CMS |
| ABBVIE INC. | $18.74 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103640818 | CMS |
| ABBVIE INC. | $16.58 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103640820 | CMS |
| ABBVIE INC. | $18.79 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103640822 | CMS |
| ABBVIE INC. | $18.54 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103640824 | CMS |
| ABBVIE INC. | $18.45 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103640826 | CMS |
| ABBVIE INC. | $16.77 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103640828 | CMS |
| ABBVIE INC. | $18.15 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103640830 | CMS |
| ABBVIE INC. | $0.85 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103640832 | CMS |
| ABBVIE INC. | $15.67 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103640834 | CMS |
| Amgen Inc. | $16.57 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111563835 | CMS |
| ANI Pharmaceuticals, Inc. | $19.50 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091163558 | CMS |
| Biogen, Inc. | $63.00 | 03/13/2024 | Education | Undisputed | 01/23/2026 | 1104846480 | CMS |
| Biogen, Inc. | $5.50 | 08/12/2024 | Education | Undisputed | 01/23/2026 | 1104874656 | CMS |
| Biogen, Inc. | $17.55 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104815517 | CMS |
| Biogen, Inc. | $17.93 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104854450 | CMS |
| Biogen, Inc. | $19.22 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104875100 | CMS |
| Biogen, Inc. | $8.28 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104828604 | CMS |
| Biogen, Inc. | $17.91 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104842122 | CMS |
| Biogen, Inc. | $10.54 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104811769 | CMS |
| Celgene Corporation | $15.23 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101080525 | CMS |
| Celgene Corporation | $15.74 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101080527 | CMS |
| EMD Serono, Inc. | $124.99 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120278566 | CMS |
| GENZYME CORPORATION | $121.38 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139851500 | CMS |
| Lilly USA, LLC | $15.06 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135088095 | CMS |
| Neurocrine Biosciences, Inc. | $20.50 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150856470 | CMS |
| Philips North America LLC | $14.73 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146893913 | CMS |
| SK Life Science, Inc. | $18.73 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154139678 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.10 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151577659 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.46 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151577839 | CMS |
| TG Therapeutics, Inc. | $115.67 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136886896 | CMS |
| TG Therapeutics, Inc. | $124.68 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136886880 | CMS |
| UCB, Inc. | $13.26 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143179726 | CMS |
| UCB, Inc. | $16.38 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143179731 | CMS |
| Vanda Pharmaceuticals Inc. | $17.59 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133901295 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.